Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
21%
ALSO IN OZEM
OZEM
22
HOLDINGS
41%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.0% | 16.2% | 10.0% |
 |
ASTRAZENECA PLC | 5.1% | 3.9% | 3.9% |
|
REGENERON PHARMACEUTICALS | 2.1% | 3.2% | 2.1% |
|
AMGEN INC | 2.0% | 3.9% | 2.0% |
|
GILEAD SCIENCES INC | 3.6% | 1.9% | 1.9% |
HRTS Overweight Relative to OZEM
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
JOHNSON & JOHNSON | 4.7% |
|
MERCK & CO. INC. | 4.4% |
|
UNITEDHEALTH GROUP INC | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
NOVARTIS AG | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
|
ABBOTT LABORATORIES | 3.1% |
|
BRIDGEBIO PHARMA, INC. | 3.0% |
|
ABBVIE INC | 2.8% |
HRTS Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -13.2% |
|
PFIZER INC | -7.1% |
|
ELI LILLY & CO | -6.2% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
 |
ASCLETIS PHARMA, INC. | -5.0% |
|
VIKING THERAPEUTICS, INC. | -4.6% |
 |
HANMI PHARM CO LTD | -3.6% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.2% |
|
ZEALAND PHARMA A/S | -3.0% |
 |
CHINA PHARMACEUTICAL GROUP | -2.9% |